Stem Cell Therapeutics (SCT; Calgary, Alberta) at this year's Stroke meeting reported favorable results from its Beta-hCG + Erythropoietin in Acute Stroke (BETAS) Phase IIa, open label, safety trial conducted at the University of California, Irvine and Hoag Presbyterian Memorial Hospital (Newport Beach, California).

NTxTM found safe in BETAS trial study for ischemic stroke

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Recognizing, Managing, and Reporting Pediatric Sexual Abuse and Assault
Eleventh Circuit Affirms Jury Verdict of $2.5 Million for Mesh Device Plaintiff Despite Close Call on Statute of Limitations
Indiana Appellate Court Allows Case to Proceed Against Doctor Accused of Improperly Accessing Patients’ Medical Records
Malpractice Insurance Rates Increasing After Stable Period
Clinical Decision Software Highly Effective in OR